Did you know that the U.S. Congress is currently considering legislation to prevent the governments of certain foreign adversaries from siphoning data and information from U.S. companies in order to advance their own capabilities in the biotechnology field? Read on for more interesting details from my OGC life sciences partner Elizabeth Dana Smith.
The BIOSECURE Act, bipartisan legislation pending before the U.S. House and Senate, is poised to impact the U.S. life sciences industry by limiting contractual relationships with certain biotechnology companies associated with foreign adversaries. OGC life sciences attorney Elizabeth Dana Smith takes a closer look at this legislation with an eye toward mitigating its potential impact. https://lnkd.in/eSAuVSP7 #OGC #lifesciences #BIOSECUREAct
